Sample profiles shown
Be the first physician listed for Oral Estradiol in your area.
Claim your listingOral Estradiol · Clinical Reference
Frequently Asked Questions
Is oral estradiol safe for menopause?
Oral 17β-estradiol is FDA-approved for moderate-to-severe vasomotor symptoms, vulvovaginal atrophy, and prevention of postmenopausal osteoporosis. Safety depends heavily on the patient's age, time since menopause, baseline cardiovascular risk, and whether she has a uterus.
The most consistent risks identified across the Women's Health Initiative (WHI), Heart and Estrogen/Progestin Replacement Study (HERS), and pooled meta-analyses are a 2–3× increase in venous thromboembolism (VTE) and a smaller increase in ischemic stroke — both driven in part by first-pass hepatic activation of clotting factors.
How is oral estradiol different from transdermal estradiol?
Oral estradiol passes through the liver before reaching circulation, which raises sex hormone-binding globulin (SHBG), triglycerides, and several clotting factors. Transdermal estradiol bypasses first-pass metabolism and shows substantially lower VTE and stroke risk in observational data (E3N, ESTHER, MEGA).
Major guidelines (NAMS 2022, Endocrine Society) now favor transdermal delivery for women with elevated VTE, stroke, or metabolic risk.
Do I need progesterone with oral estradiol?
Yes — any woman with an intact uterus taking systemic estrogen requires a progestogen to prevent endometrial hyperplasia and adenocarcinoma. Unopposed estrogen raises endometrial cancer risk roughly 5–10× over 5+ years of use.
Micronized progesterone is the preferred option in current guidelines based on the E3N and KEEPS data suggesting a more favorable breast and cardiovascular profile than older synthetic progestins like medroxyprogesterone acetate.
Does oral estradiol increase breast cancer risk?
Estrogen alone (in women without a uterus) showed no increase — and a possible decrease — in invasive breast cancer in the WHI estrogen-alone arm after ~7 years of follow-up. Risk increases were observed mainly in the estrogen + medroxyprogesterone arm.
Risk modifiers include duration of use, type of progestogen, baseline density, and family history. Discuss individual risk with a prescriber familiar with menopausal hormone therapy.
Is oral estradiol FDA-approved?
Yes. Oral micronized 17β-estradiol is FDA-approved (Estrace and generics) for vasomotor symptoms, vulvovaginal atrophy, and osteoporosis prevention. Multiple combination products pair it with a progestogen for women with a uterus.
How long does oral estradiol take to work?
Hot flashes and night sweats usually improve within 2–4 weeks, with maximal benefit by 8–12 weeks. Vulvovaginal symptoms can take 8–12 weeks. Bone density benefits accrue over 12+ months of continuous use.
Can I get oral estradiol without a prescription?
No. Oral estradiol is a prescription medication and requires evaluation by a licensed clinician, including a discussion of cardiovascular, VTE, and breast cancer risk before initiation.
How do I find a doctor who prescribes oral estradiol?
TruthTides maintains a directory of clinicians experienced with menopausal hormone therapy. Filter by state, telehealth availability, and HRT expertise to find a prescriber.
Find a prescriber near you →